Advanced Breast Cancer (ABC6; ABC Global Alliance) was held virtually on November 4-6, 2021.
Read below for news coming out of this conference, including a report about doubled survival times for people with two of the most common subtypes of MBC, COVID-19 vaccination recommendations, and results from a survey about participation in clinical trials by people with advanced breast cancer.
- EurekAlert Average survival time has doubled for some subytpes of MBC
- EurekAlert COVID-19 vaccination recommendations
- Medical Xpress Advanced breast cancer patients denied opportunities to join clinical trials
Last Modified on December 13, 2021